<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04264000</url>
  </required_header>
  <id_info>
    <org_study_id>PRP for ulnar neuropathy</org_study_id>
    <nct_id>NCT04264000</nct_id>
  </id_info>
  <brief_title>Platelet-rich Plasma Injection for Ulnar Neuropathy at Elbow</brief_title>
  <official_title>Platelet-rich Plasma Injection for Ulnar Neuropathy at Elbow: A Randomized Double-blind Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yung-Tsan Wu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tri-Service General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ulnar neuropathy at elbow (UNE) is the second common peripheral entrapment neuropathy after
      carpal tunnel syndrome (CTS). Although many conservative managements of UNE were found, their
      effectiveness were often unsatisfied without existed guideline. Recently, the perineural
      injection of 5% dextrose wate (D5W) is a novel management for CTS but its effect for UNE is
      not obviously as CTS. Hence, it is very important to find another novel injectate for UNE.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The platelet-rich plasma (PRP) is a new and potential treatment for patients with kinds of
      musculoskeletal disorders and recent reports showed being beneficial for peripheral
      neuropathy in animal studies. Our previous research shown single injection with PRP was
      superior to D5W for CTS. However there is no study investigating the effect of PRP for UNE
      now. Hence, the purpose of this study was to assess the effect of perineural PRP injection
      for UNE.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">August 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analog scale (VAS)</measure>
    <time_frame>Change from baseline at 6 month after injection</time_frame>
    <description>Digital pain severity or paresthesia/dysthesia was evaluated using VAS. Pain score scale ranged from 0 to 10, with 10 indicating the most severe pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disabilities of the Arm, Shoulder and Hand (DASH)</measure>
    <time_frame>Change from baseline at 6 month after injection</time_frame>
    <description>Taiwan Disabilities of the Arm, Shoulder and Hand (DASH) contains 11-item disability/symptom scale and each item has five levels of response scoring from 1 to 5. The higher score means more disability or severer symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrophysiological study</measure>
    <time_frame>Change from baseline at 6 month after injection</time_frame>
    <description>Nerve motor conduction velocity of the ulnar nerve before treatment and multiple time frame after treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cross-sectional area of ulnar nerve</measure>
    <time_frame>Change from baseline at 6 month after injection</time_frame>
    <description>Using the musculoskeletal sonogram to measure the cross-sectional area of the ulnar nerve before treatment and multiple time frame after treatment.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Ulnar Neuropathy at Elbow</condition>
  <arm_group>
    <arm_group_label>platelet-rich plasma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The perineural injection with PRP is a potential treatment for peripheral entrapment neuropathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5% dextrose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The perineural injection of 5% dextrose is a novel management for peripheral entrapment neuropathy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>platelet-rich plasma</intervention_name>
    <description>Ultrasound-guided 3cc PRP injection between medial epicondyle and ulnar nerve</description>
    <arm_group_label>platelet-rich plasma</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>5% dextrose</intervention_name>
    <description>Ultrasound-guided 3cc 5% dextrose injection between medial epicondyle and ulnar nerve</description>
    <arm_group_label>5% dextrose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age between 20-80 year-old.

          2. Diagnosis as ulnar neuropathy at elbow at least one month

        Exclusion Criteria:

          1. Cancer

          2. Coagulopathy

          3. Pregnancy

        3. Any active infection status 4. Polyneuropathy of upper extremity 5. Brachial plexopathy
        6. Thrombocytopenia Previously undergone wrist surgery or steroid injection for ulnar
        neuropathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yung-Tsan Wu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yung-Tsan Wu</last_name>
    <phone>+886287923311</phone>
    <email>crwu98@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Yung-Tsan Wu</name>
      <address>
        <city>Taipei</city>
        <state>Neihu District</state>
        <zip>886</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <contact>
      <last_name>Yung-Tsan Wu</last_name>
      <phone>0287923311</phone>
      <email>crwu98@gmail.com</email>
    </contact>
    <contact_backup>
      <phone_ext>Wu</phone_ext>
      <email>crwu98@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Yung-Tsan Wu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <results_reference>
    <citation>Shen YP, Li TY, Chou YC, Ho TY, Ke MJ, Chen LC, Wu YT. Comparison of perineural platelet-rich plasma and dextrose injections for moderate carpal tunnel syndrome: A prospective randomized, single-blind, head-to-head comparative trial. J Tissue Eng Regen Med. 2019 Nov;13(11):2009-2017. doi: 10.1002/term.2950. Epub 2019 Aug 20.</citation>
    <PMID>31368191</PMID>
  </results_reference>
  <results_reference>
    <citation>Wu YT, Ke MJ, Ho TY, Li TY, Shen YP, Chen LC. Randomized double-blinded clinical trial of 5% dextrose versus triamcinolone injection for carpal tunnel syndrome patients. Ann Neurol. 2018 Oct;84(4):601-610. doi: 10.1002/ana.25332. Epub 2018 Oct 4.</citation>
    <PMID>30187524</PMID>
  </results_reference>
  <results_reference>
    <citation>Wu YT, Ho TY, Chou YC, Ke MJ, Li TY, Huang GS, Chen LC. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: A prospective randomized, single-blind controlled trial. Sci Rep. 2017 Dec;7(1):94. doi: 10.1038/s41598-017-00224-6. Epub 2017 Mar 7.</citation>
    <PMID>28273894</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 4, 2020</study_first_submitted>
  <study_first_submitted_qc>February 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2020</study_first_posted>
  <last_update_submitted>February 7, 2020</last_update_submitted>
  <last_update_submitted_qc>February 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Tri-Service General Hospital</investigator_affiliation>
    <investigator_full_name>Yung-Tsan Wu</investigator_full_name>
    <investigator_title>Attending Physician and associated professor of Department of Physical Medicine and Rehabilitation</investigator_title>
  </responsible_party>
  <keyword>Ulnar Neuropathy at Elbow</keyword>
  <keyword>platelet-rich plasma</keyword>
  <keyword>Perineural injection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
    <mesh_term>Ulnar Neuropathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

